Michael Metzger
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Metzger
Michael Metzger is recorded as CEO at Syndax Pharmaceuticals Inc (SNDX). Michael Metzger has spoken on 20 earnings calls across 1 company, most recently for Syndax Pharmaceuticals Inc on August 4, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Syndax Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Michael A. Metzger CEO, Board Member
- Daphne Karydas CFO
- Keith A. Goldan CFO
- Keith Goldan CFO
- Luke J. Albrecht General Counsel
- Aleksandra Rizo, M.D., Ph.D. Board Member
- Martin H. Huber, M.D. Board Member
- Pierre Legault Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.